These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 23845922)
1. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Arnold DM; Nazi I; Warkentin TE; Smith JW; Toltl LJ; George JN; Kelton JG Transfus Med Rev; 2013 Jul; 27(3):137-45. PubMed ID: 23845922 [TBL] [Abstract][Full Text] [Related]
2. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. Arnold DM; Kukaswadia S; Nazi I; Esmail A; Dewar L; Smith JW; Warkentin TE; Kelton JG J Thromb Haemost; 2013 Jan; 11(1):169-76. PubMed ID: 23121994 [TBL] [Abstract][Full Text] [Related]
7. Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG. Liang SX; Pinkevych M; Khachigian LM; Parish CR; Davenport MP; Chong BH Blood; 2010 Sep; 116(11):1958-60. PubMed ID: 20566900 [TBL] [Abstract][Full Text] [Related]
9. Piperacillin and vancomycin induced severe thrombocytopenia in a hospitalized patient. Anand A; Chauhan HK Platelets; 2011; 22(4):294-301. PubMed ID: 21309645 [TBL] [Abstract][Full Text] [Related]
13. Treatment of drug-induced immune thrombocytopenias. Marini I; Uzun G; Jamal K; Bakchoul T Haematologica; 2022 Jun; 107(6):1264-1277. PubMed ID: 35642486 [TBL] [Abstract][Full Text] [Related]
14. Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia. Bougie DW; Nayak D; Boylan B; Newman PJ; Aster RH Blood; 2010 Oct; 116(16):3033-8. PubMed ID: 20587782 [TBL] [Abstract][Full Text] [Related]
15. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. George JN; Aster RH Hematology Am Soc Hematol Educ Program; 2009; ():153-8. PubMed ID: 20008194 [TBL] [Abstract][Full Text] [Related]
16. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Warkentin TE; Hayward CP; Boshkov LK; Santos AV; Sheppard JA; Bode AP; Kelton JG Blood; 1994 Dec; 84(11):3691-9. PubMed ID: 7949124 [TBL] [Abstract][Full Text] [Related]
17. Vancomycin-dependent antibodies associated with thrombocytopenia and refractoriness to platelet transfusion in patients with leukemia. Christie DJ; van Buren N; Lennon SS; Putnam JL Blood; 1990 Jan; 75(2):518-23. PubMed ID: 2295006 [TBL] [Abstract][Full Text] [Related]
18. Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia. Rondina MT; Walker A; Pendleton RC Hosp Pract (1995); 2010 Apr; 38(2):19-28. PubMed ID: 20469610 [TBL] [Abstract][Full Text] [Related]
19. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Reese JA; Li X; Hauben M; Aster RH; Bougie DW; Curtis BR; George JN; Vesely SK Blood; 2010 Sep; 116(12):2127-33. PubMed ID: 20530792 [TBL] [Abstract][Full Text] [Related]
20. Acute drug-induced immune thrombocytopenia - A work of articaine. Laegreid IJ; Olsen MI; Harr JI; Grønli RH; Mørtberg TV; Ernstsen SL; Ahlen MT Transfusion; 2022 May; 62(5):1142-1147. PubMed ID: 35305268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]